SCOTUS Grapples With Marketing of Vascepa Generic With 'Skinny Label'

(MedPage Today) -- How far can a generic drugmaker with a so-called skinny label go in publicizing a generic version of a brand-name drug? The Supreme Court heard arguments on this question Wednesday, but didn't give a clear indication of which...
Source
MedPage Today
Opens original article in a new tab



